National Council for Behavioral Health

Contact: [email protected] | 202.684.7457

www.TheNationalCouncil.org

National CouncilNational Councilfor Behavioral for Behavioral

HealthHealth


This presentation at a glance

Role of data in the healthcare system of the future

How will information be used and data shared under health reform

Using Data for Population Management Health Information Exchange/DIRECT Secure

Messaging Meaningful Use – opportunities now Meaningful Use – Opportunities in the Future Strategies to Position your Organization


Innovations under CMS

• Payment reform; fundamental shift away from fee-for-service

• Delivery system reform: encourage reorganization of system to take out waste and deliver high‐value care

• Different opportunities for providers based on readiness

• Strategic partnerships with data• Robust quality monitoring• Emphasis on multi‐payer strategies

and approachesJonathan Blum, CMS


…and from a business planning perspective• Shifts in revenue sources

as more people become eligible and enroll in new insurance options

• Increased competition as health providers meet new value-based purchasing standards built on health system partnerships and accountability for clinical outcomes


Connect with other providers

Coverage expansions are ONLY sustainable with delivery system reform Collaborative Care Patient Centered Healthcare

Homes Accountable Care Organizations

Accountability and quality improvement are hallmarks of the new healthcare ecosystem



Using Data for Population Based Interventions

6


Sharing Information is the Standard

Health Information Exchange RULES!

Integration and improved outcomes will only be successful if we can share information

7


CostRank Treatment Type

Total Charges No of members Average Charges per Member

1 Community Support Services/15 min $2,890,038 218 $13,257

2 Community Support Services /day $1,916,375 181 $10,588

3 Personal care per diem $1,394,614 123 $11,338

4 Habilitation, prevocational/15 min $758,157 104 $7,290

5 Supported employment/15 min $713,680 154 $4,634

6 Inpatient room and board $699,602 90 $7,773

7 Targeted case management/15 min $557,154 689 $1,009

8 Inpatient- ancillaries $494,577 81 $6,878

9 Case management/ 15 min $438,577 470 $1,052

10 Emergency room $356,478 247 $1,776

11 Psych medication management $356,478 1,086 $328

12 Inpatient-facility charges $288,479 52 $5,548

13 Labs $287,935 437 $659

14 ACT program $286,773 115 $2,494

15 Medical supplies $241,812 156 $1,550

16 Family therapy $221,136 181 $1.222

24 Office visits – primary care $154,773 616 $215

29 Surgery $105,085 98 $1,072

36 Ambulance $54,581 67 $815

8


Table of top cost by diagnosis, January-March,2006

CostRank

Primary Diagnosis Total Charges No of Members Average Charges Per Member

1 Schizophrenia and Affective Psychosis $6,167,527 1,102 $5,597

2 Depression/Anxiety/Neuroses $1,710,759 347 $4,930

3 Moderate Mental Retardation $1,040,669 112 $9,292

4 Severe Mental Retardation $1,032,094 74 $13,947

5 Profound Mental Retardation $982,760 39 $25,199

6 Mild Mental Retardation $709,344 131 $5,415

7 Alcohol and Drug Abuse $283,077 177 $1,599

8 Pregnancy $183,653 39 $4,709

9 Congestive heart Failure $168,130 7 $24,019

10 Chest Pain $161,260 65 $2,481

11 All Fractures and Dislocations $137,901 19 $7,258

12 Diabetes Mellitus $134,161 42 $3,194

9


Cost By Service Type

Top Cost by Treatment Type January-March, 2006

Community SupportServices/15 min

Community Support Services/day

Personal care per diem

Habilitation, prevocational/15min

Supported employment/15 min

Inpatient room and board

Targeted casemanagement/15 min

Inpatient- ancillaries

Case management/ 15 min

Emergency room

10


Cost Data by Primary Diagnosis

11



Using Data for Individual Interventions

12


High Utilizer Report

• 3 consumers with an average cost of $272,652 each

• Drill down: Consumer with brittle diabetes and personality disorder - frequent ER and inpatient

• 4 consumers with average cost of $236,434 each• Drill down: Consumer with SUD without motivation &

personality disorder; multiple complex medical conditions

• 4 Consumers with average cost of $85,867 each• Drill down: Consumer with SUD- frequent detox ;lack

of community services

13


Case #1

14


Case 1: Continued

15


$0

$10,000

$20,000

$30,000

$40,000

$50,000

$60,000

Jul-05 Aug-05 Sep-05 Oct-05 Nov-05 Dec-05

Charges

16

Timeframe Jul2005 Aug2005 Sep2005 Oct2005 Nov2005 Dec2005

Charges $49,010 $52,632 $18,050 $27,376 $42,493 $8,058


Measuring Disparities

17


CDC Sortable Stats http://wwwn.cdc.gov/sortablestats

18

Contact: [email protected] | 202.684.7457 19

At Risk Criteria

Blood pressure combinedSystolic greater than 130 OR Diastolic greater than 85

BMIGreater than or equal to 25

Waist circumferenceMale, greater than 102 cmFemale, greater than 88 cm

Breath COGreater than or equal to 10

Fasting Plasma GlucoseGreater than 100

HgbA1cGreater than or equal to 5.7

CholesterolHDL, less than 40LDL, greater than or equal to 130Triglycerides, greater than or equal to 150

Others that the organizations determine

Chronic Medical Conditions










Sharing Information is the Standard

Health Information Exchange RULES!

Integration and improved outcomes will only be successful if we can share information

28

Contact: [email protected] | 202.684.7457 2904/21/23

Flavors of Health Information Exchange


September 9, 2013Office of the National Coordinator (ONC) Issued:

Certification Guidance for EHR Technology Developers Serving Health Care Providers Ineligible for Medicare and Medicaid EHR Incentive Payments


Purpose: Guidance is meant to serve as a building block for federal agencies and stakeholders to use as they work with different communities to achieve interoperable electronic health information exchange.


2014 Edition EHR Certification Criterion

Short Description3

45 CFR §170.314(b)(1) 45 CFR §170.314(b)(2) Transitions of Care

These two certification criteria require EHR technology to be, at a minimum, capable of: A) electronically creating and receiving summary care records with a common data set in accordance with the Consolidated Clinical Document Architecture (CCDA) standard; and B) electronically exchanging in accordance with the Direct transport specification.

45 CFR §170.314(b)(4) Clinical Information Reconciliation

Require EHR technology to allow a user to electronically reconcile the data that represent a patient’s active medication, problem, and medication allergy list.


Exchange Among Providers in One system

Somewhat Difficult but Occurring Nationally


Exchange Among Providers in Multiple Systems

More Difficult but Occurring Nationally


Secure Messaging ExchangeUses DIRECT Protocols

Meets Meaningful Use Requirements

EasyI encourage ALL providers to obtain and DIRECT Address!!

Even if you DO NOT have an EHR!!


Addressing ConfidentialityCommon Barrier If not addressed, promotes stigmaRI leads the nation through its work with the

SAMHSA/HRSA Center for Integrated Health Solutions

MH & SU Information can be shared securely in RIKY will follow soonThere are ways to work within 42 CFR Part 2

36


Meaningful UseOpportunities Now

37


Revised Definition of CEHRT Effective Dates

There is no such thing as being “Stage 1 Certified” or “Stage 2 Certified” – 2014 Edition EHR technology would be able to support the achievement of either meaningful use Stage.

EHR Reporting Period

FY/CY 2011 FY/CY 2012 FY/CY 2013 FY/CY 2014

MU Stage 1 MU Stage 1 MU Stage 1 MU Stage 1 or MU Stage 2

All EPs, EHs, and CAHs must have:

1)EHR technology that has been certified to all applicable 2011 Edition EHR certification criteria or equivalent 2014 Edition EHR certification criteria adopted by the Secretary; or

2) EHR technology that has been certified to the 2014 Edition EHR certification criteria that meets the Base EHR definition and would support the objectives, measures, and their ability to successfully report CQMs, for MU Stage 1.

All EPs, EHs, and CAHs must have EHR technology certified to the 2014 Edition EHR certification criteria that meets the Base EHR definition and would support the objectives, measures, and their ability to successfully report the CQMs, for the MU stage that they seek to achieve.


2014 Edition CEHRT Easy as

1, 2, 3 + C* What varies is the quantity of EHR technology certified to the 2014 Edition EHR certification criteria that would be necessary to be used to meet MU

EP/EH/CAH would only need to have EHR technology with capabilities certified for the MU menu set objectives & measures for the stage of MU they seek to achieve.

EP/EH/CAH would need to have EHR technology with capabilities certified for the MU core set objectives & measures for the stage of MU they seek to achieve unless the EP/EH/CAH can meet an exclusion.

EP/EH/CAH must have EHR technology with capabilities certified to meet the Base EHR definition.

Base EHR

1


2014 Edition EHR Certification Criteria Mapped to the 2014 CEHRT

Definition for EHs & CAHs Seeking to Achieve MU Stage 2 in and after CY 2014

2014 Certification Criteria associated with MU Core Stage 2: •Drug-drug, drug-allergy interaction checks (170.314(a)(2))

•Vital signs, BMI, & growth charts (170.314(a)(4))

•Smoking status (170.314(a)(11))

•Patient list creation (170.314(a)(14))

•Patient-specific education resources (170.314(a)(15))

•eMAR (170.314(a)(16))

•Clinical information reconciliation (170.314(b)(4))

•Incorporate lab tests & values/results (170.314(b)(5))

•View, download, & transmit to 3rd Party (170.314(e)(1))

•Immunization information (170.314(f)(1))

•Transmission to immunization registries (170.314(f)(2))

•Transmission to PH agencies – syndromic surveillance (170.314(f)(3))

•Transmission of reportable lab tests & values/results (170.314(f)(4))

2014 Certification Criteria associated with a Base EHR: >CPOE (170.314(a)(1)) >Demographics (170.314(a)(3)) >Problem list (170.314(a)(5)) >Medication list (170.314(a)(6)) >Medication allergy list (170.314(a)(7)) >Clinical decision support (170.314(a)(8)) >Transitions of care (170.314(b)(1) & (2)) >Data portability (170.314(b)(7)) >Clinical quality measures (170.314(c)(1) - (3)) >Privacy and Security CC:

o Authentication, access control, authorization (170.314(d)(1))

o Auditable events & tamper resistance (170.314(d)(2)) o Audit report(s) (170.314(d)(3))o Amendments (170.314(d)(4))o Automatic log-off (170.314(d)(5))o Emergency access (170.314(d)(6))o End-user device encryption (170.314(d)(7)) o Integrity (170.314(d)(8)) o Accounting of disclosures* (170.314(d)(9))

2014 Certification Criteria associated with MU Menu Stage 2: >Electronic notes (170.314(a)(9)) >Drug-formulary checks (170.314(a)(10)) >Image results (170.314(a)(12)) >Family health history (170.314(a)(13)) >Advance directives (170.314(a)(17)) >eRx (170.314(b)(3)) >Transmission of e-lab tests & values/results to providers (170.314(b)(6))

2014 ed. certification criteria for which certification may be required: >Automated numerator recording (170.314(g)(1)) >Automated measure calculation (170.314(g)(2)) >Safety-enhanced design (170.314(g)(3)) >Quality management system (170.314(g)(4))

* optional


Do you have EHR Technology that meets the new Certified EHR Technology definition

for Meaningful Use Stage 1?

START HERE

Do you have a 2014 Edition Complete EHR for the Ambulatory (EPs) or Inpatient (EHs/CAHs) Setting?

Is your EHR technology certified to the following certification criteria required to meet the Base EHR definition? § 170.314: (a)(1),(3)&(5-8) – CPOE/Demogfrx/ProbList/ MedList/MedAllergyList/CDS (b)(1),(2)&(7) – TOC/Data Port (c)(1)-(3) – CQMS (d)(1)-(8) – P&S

Do you have EHR technology that has been: Certified to ≥ 16 CQMs from

CMS’ selected set for EH/CAHs

Address ≥ 3 domains from the set selected by CMS for EH/CAHs?

Is your EHR technology certified to the following certification criteria to support the MU1 EH/CAH Core Objectives you seek to achieve and for which you cannot meet a MU exclusion? § 170.314:

(a)(2) – DD/DA (a)(11) – Smoking (a)(4) – Vitals (e)(1) – VDTx3

Is your EHR technology certified to the following certification criteria to support the MU1 EH/CAH Menu Objectives you seek to meet? § 170.314:

(a)(10) – RxFormulary (b)(5) – Incorp Lab (a)(14) – Pt List (f)(1) – Immz Info (a)(15) – Pt Edu (f)(2) – Immz Tx (a)(17) – AD (f)(3) – Syn Surv (b)(4) – ClinInfoRec (f)(4) – ELR

Do you have EHR technology that has been: Certified to ≥ 9 CQMs ≥ 6 from CMS’ recommended core set Address ≥ 3 domains from the set selected by CMS for EPs?

Is your EHR technology certified to the following certification criteria to support the MU1 EP Core Objectives you seek to achieve and for which you cannot meet a MU exclusion? § 170.314:

(a)(2) – DD/DA (b)(3) – eRx (a)(4) – Vitals (e)(1) – VDTx3 (a)(11) – Smoking (e)(2) – Clinical Sum

Is your EHR technology certified to the following certification criteria to support the MU1 EP Menu Objectives you seek to meet? § 170.314:

(a)(10) – RxFormulary (b)(5) – Incorp Lab (a)(14) – Pt List (f)(1) – Immz Info (a)(15) – Pt Edu (f)(2) – Immz Tx (b)(4) – ClinInfoRec (f)(3) – Syn Surv

EH/CAH

Note: To meet the CEHRT definition, EHR technology will need to have been certified to: Automated numerator recording (170.314(g)(1)) or Automated measure calculation (170.314(g)(2)); Safety-enhanced design (170.314(g)(3)); and Quality management system (170.314(g)(4))


Stage 2 Resources

CMS Stage 2 Webpage: •http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Stage_2.html

Links to the Federal Register Tipsheets:

•Stage 2 Overview

•2014 Clinical Quality Measures

•Payment Adjustments & Hardship Exceptions (EPs & Hospitals)

•Stage 1 Changes

•Stage 1 vs. Stage 2 Tables (EPs & Hospitals)


Clinical Quality Measures

43


CQM Alignment with HHS Priorities

All providers must select CQMs from at least 3 of the 6 HHS National Quality Strategy domains:

• Patient and Family Engagement

• Patient Safety

• Care Coordination

• Population and Public Health

• Efficient Use of Healthcare Resources

• Clinical Processes/Effectiveness


CQMs in 2014 and Beyond

CQMs change in 2014:

* Regardless of the stage of meaningful use, all providers will complete this number of CQMs in 2014.

Core Objective Measure 2014 and Beyond*

EPs Complete 6 out of 44

• 3 core or 3 alt. core • 3 menu

Complete 9 out of 64

Choose at least 1 measure in 3 NQS domains

Recommended core CQMs include: • 9 CQMs for the adult population • 9 CQMs for the pediatric population • Prioritize NQS domains

Eligible Hospitals and CAHs

Complete 15 out of 15 Complete 16 out of 29

• Choose at least 1 measure in 3 NQS domains



Clinical Quality Measures

Behavioral Health Specific Clinical Quality Measures



NQF 0105

Title: Anti-depressant medication management: (a)Effective Acute Phase Treatment(b)Effective Continuation Phase Treatment Description: The percentage of patients 18 years of age and older who were diagnosed with a new episode of major depression, treated with antidepressant medication, and who remained on an antidepressant medication treatment. Two rates are reported.

a)Percentage of patients who remained on an antidepressant medication for at least 84 days (12 weeks)b)Percentage of patients who remained on an antidepressant medication for at least 180 days (6 months)



NQF 0004Title: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement Description: The percentage of patients 13 years of age or older

With a new episode of alcohol and other drug (AOD)dependence who received the following. Two rates are reported:

a) Percentage of patients who initiated treatment within 14days of the diagnosis

b) Percentage of patients who initiated treatment and who

had two or more additional services with an AOD diagnosis within 30 days of the initiation visit



NQF 0028

Title: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

Description: Percentage of patients aged 18 years andolder who were screened for tobacco use one or more times within 24 months AND received cessation counseling intervention if identified as a tobacco user



0022Title: Use of High-Risk Medications in the Elderly

Description: Percentage of patients ages 65 years and older who received at least one high-risk medication. Percentage of patients 65 years of age and older who received at least two different high-risk medications.

a: Percentage of Patients who were ordered at least one high-risk medication

b: Percentage of Patients who were ordered least two high-risk medications during the measurement year



0101 Title: Falls: Screening for Fall Risk

Description: Percentage of patients aged 65 years and older who were screened for future fall risk during the measurement period



0104 Title: Major Depressive Disorder (MDD): Suicide Risk Assessment

Description: Percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD who had a suicide risk assessment completed at each visit during the measurement period.



0108 Title: ADHD: Follow-Up Care for Children Prescribed Attention Deficit Hyperactivity Disorder (ADHD) Medication

Description: Percentage of children 6-12 years of age as of age and newly dispensed a medication for attention deficit/hyperactivity disorder (ADHD) who had appropriate follow up care. Two rates are reported

a. Initiation Phase: Percentage of children who had one follow up visit with a practitioner with prescribing authority during the 30-day Initiation Phase

b. Percentage of children who remained on ADHD medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two additional follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended



0110 Title: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use

Description: Percentage of patients with depression or bipolar disorder with evidence of an initial assessment that includes an appraisal for alcohol or chemical substance use.



0418 Title: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan

Description: Percentage of patients aged 12 years and older screened for clinical depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow up plan documented is documented on the date of the positive screen.



0419 Title: Documentation of Current Medications in the Medical Record

Description: Percentage of specified visits for patients 18 years and older for which the eligible professional attests to documenting a list of current medications to the best of his/her knowledge and ability. This list must include ALL prescriptions, over the counter, herbals and vitamin/mineral/dietary (nutritional) supplements AND must contain the medications’ name, dosage, frequency and route of administration



0421 Title: Adult Weight Screening and Follow-Up

Description: Percentage of patients aged 18 years and older with a calculated body mass index (BMI) in the past six months or during the current reporting period documented in the medical record AND if the most recent BMI is outside of normal parameters, a follow-up plan is documented within the past six months or during the current reporting period.

Normal Parameters: Age 65 years and older BMI ≥ 23 and < 30 Age 18-64 years BMI ≥ 18.5 and < 25



0710 Title: Depression Remission at Twelve Months

Description: Adult patients age 18 and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate remission at twelve months defined as PHQ-9 score less than 5. This measure applies to both patients with newly diagnosed and existing depression whose current PHQ-9 score indicates a need for treatment.



0712 Title: Depression Utilization of the PHQ-9 Tool

Description: Adult patients age 18 and older with the diagnosis of major depression or dysthymia who have a PHQ-9 tool administered at least once during a 4 month period in which there was a qualifying visit.



1365 Title: Child and Adolescent Major Depressive Disorder: Suicide Risk Assessment

Description: Percentage of patient visits for those patients aged 6 through 17 years with a diagnosis of major depressive disorder with an assessment for suicide risk.



Not yet endorsed

Title: Dementia: Cognitive Assessment

Description: Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of cognition is performed and the results reviewed at least once within a 12-month period.



https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/Downloads/Eligible-Providers-2014-Proposed-EHR-Incentive-Program-CQM.pdf


How Will the Data be Shared?

63


Data Integrity Follow the Continuity of Care

Document / C-CDA


Psycho-therapy Notes are not Sent




What Will This Data Look Like?

68


Good Health Clinic Continuity of Care Document

Created On: January 6, 2012

Patient

Henry Levin , the 7th

Birthdate September 24, 1932

Guardian Kenneth Ross 17 Daws Rd.

Blue Bell, MA, 02368 tel:(888)555-1212

MRN 996-756-495

Sex Male

Next of Kin Henrietta Levin

tel:(999)555-1212

Table of Contents

Purpose Payers Diagnosis Allergies, Adverse Reactions, Alerts Medications Immunizations Results Treatment Plan Progress Note Suicide Risk Risk of Violence Substance Abuse

Purpose

Transfer of care


Payers

Payer name Policy type / Coverage type Covered party ID Authorization(s) Healthy Insurance Extended healthcare / Self 14d4a520-7aae-11db-9fe1-0800200c9a66

Diagnosis

Axis I Primary : 296.21 - Major Depressive Disorder , Single Episode Axis I Secondary : 303.90 - Alcohol Dependence Axis II Primary : 301.6 - Dependent Personality Disorder Axis III : None Axis IV : Social Environment (Recently divorced), Occupational (Recently unemployed), Housing (Recently lost

home to foreclosure and is homeless), Other Problems (Recent evidence of male pattern baldness) AxisV:58


Allergies, Adverse Reactions, Alerts

Substance Reaction Status Penicillin Hives Active Aspirin Wheezing Active Codeine Nausea Active

Medications

Medication Instructions Start Date Status Albuterol inhalant 2 puffs QID PRN wheezing

Active

Clopidogrel (Plavix) 75mg PO daily

Active Metoprolol 25mg PO BID

Active

Prednisone 20mg PO daily Mar 28, 2000 Active Cephalexin (Keflex) 500mg PO QID x 7 days (for bronchitis) Mar 28, 2000 No longer active


Immunizations

Vaccine Date Status Source of Information Influenza virus vaccine Nov 1999 Completed Immunization Tracking System Influenza virus vaccine Dec 1998 Completed Immunization Tracking System Pneumococcal polysaccharide vaccine Dec 1998 Completed Immunization Tracking System Tetanus and diphtheria toxoids 1997 Completed Immunization Tracking System

Results

March 23, 2011 April 06, 2011

Hematology HGB (M 13-18 g/dl; F 12-16 g/dl) 13.2

WBC (4.3-10.8 10+3/ul) 6.7

PLT (135-145 meq/l) 123*

Chemistry NA (135-145meq/l)

140

K (3.5-5.0 meq/l)

4.0 CL (98-106 meq/l)

102

HCO3 (18-23 meq/l)

35*


Treatment Plan

Problem 05-Substance Abuse

Goal Accept chemical dependence and begin to actively participate in a recovery program.

Objective Describe childhood experience of alcohol abuse by immediate and extended family members.

Goal Establish a sustained recovery, free from the use of all mood-altering substances.

Objective Develop a right aftercare plan that will support the maintenance of long-term sobriety.

Progress Note

02/04/2009 Henry Levin was assessed and completed testing. He showed signs of alcohol dependence as evidenced by marked tolerance, previous attempts at abstinence, relationship problems as well as hangovers and blackouts. He also has a previous OWI and completed Level I with this program in 2007. Referred to XYZ Counseling Center for IOP. Baseline UA taken.


Suicide Risk

Suicide Thoughts?

Date of Last Suicidal Thought

Risk Factors Previous

attempts? Date of Last

Attempt Additional

Information

Yes 04/15/2009 Guns in house, potentially

lethal medications Yes - 1 11/27/1989

Recently lost job, feeling despondent

Risk of Violence

Threat towards others?

Existence of Plan

Plan details Level of Intent

History of Violence?

History details Risk

Factors Additional

Information

Yes Moderate

Plan

Reduce the risk of domestic

violence Minor Yes

Assault on 1 individual with deadly weapon

Guns in house

No vehicle to carry out plan

Substance Abuse

Substance Route Frequency Age of First Use Date of Last Use

Primary Methamphetamine Injection 3-6 times in the past week 15 05/04/2009 Secondary Methylphenidate Oral 1-2 times in the past week 17 04/27/2009

Electronically generated by: on January 6, 2012


Meaningful UseOpportunities in the Future

75


The National Council promotes a mental health and addiction policy agenda that supports a strong mental health and addiction safety net. Our public policy agenda includes:Establishing federal status for community behavioral health organizations, as outlined in the Excellence in Mental Health Act

Promoting federal initiatives that support public education on mental illness and addiction such as the Mental Health First Aid Act

Working to ensure that behavioral health providers are eligible for health information technology incentives, as in the Behavioral Health IT Act

Ensuring behavioral health’s full inclusion in health reform implementationProtecting federal funding for Medicaid and protecting beneficiaries and providers

Preserving funding for other important behavioral health programs such as those funded by the Substance Abuse and Mental Health Services Administration

76

Mental Health and Addiction Policy Agenda



77


Strategies to Position Yourself to Effectively Use Data

78


Focus on InteroperabilityObtain a DIRECT Secure Messaging AddressSpeak to your vendor about compatibility with the C-CDASelect Clinical Quality Measures that the rest of health care is using

Then add your ownBegin sharing data with your health care partners



80

These Changes are Coming!!!!



81


Michael R. Lardiere, LCSW Vice President, HIT & Strategic Development [email protected]

•Website: www.thenationalcouncil.org•CIHS: www.integration.samhsa.gov •Blog: www.MentalHealthcareReform.org •Twitter: @nationalcouncil•Facebook: www.facebook.com/TheNationalCouncil

Documents

National Council for Behavioral Health